Viewing nowCombinationEmpagcan Duo Tablet 12.5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.

MFDS item code 202501730 · Approved 2025.07.09 · Insurance code 642907030
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to effectively improve blood glucose control in adults with type 2 diabetes when combined with dietary and exercise therapy. Special attention should be paid to the occurrence of cardiovascular events in patients with type 2 diabetes whose blood glucose is not adequately controlled. Clinical trial information related to this is available in expert guidelines. Therefore, this medication is used to improve blood glucose control and assist in managing cardiovascular risk in diabetes treatment.
The recommended dose of this drug is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended dose when taking this drug is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this drug from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this drug is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This drug should be taken with meals to reduce gastrointestinal adverse effects associated with metformin. If you miss a dose of this drug, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this drug contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this drug is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this drug should be discontinued immediately (see Precautions for Use, 2. Patients in Whom the Drug Is Contraindicated, item 2)). Elderly Patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication is primarily used for the treatment of type 2 diabetes. Serious adverse effects such as lactic acidosis may occur, so caution is needed during administration. Caution should also be exercised when using with other diabetes treatments as hypoglycemic symptoms may appear. Patients with moderate to severe kidney dysfunction or acute renal impairment should not use this medication. Patients with acute infections, dehydration, cardiovascular problems, or liver dysfunction should also avoid taking this medication. It is safe for pregnant or breastfeeding women to refrain from using this medication. This medication may increase the risk of urinary tract infections and genital infections, so patients should report any related symptoms to their doctor immediately. Regular kidney function and blood tests are important to monitor for abnormalities during use. Hypoglycemic symptoms may occur, so irregular meals, excessive exercise, and alcohol consumption should be avoided. If surgery is scheduled or iodine contrast tests are to be performed, this medication should be discontinued for a certain period. Elderly patients or those at risk of fluid loss should take care to avoid dehydration and hypotension during administration. As vitamin B12 deficiency may occur, it is advisable to check blood vitamin B12 levels during prolonged use. Patients should refrain from consuming alcohol while taking this medication and consult medical personnel immediately in case of any symptoms occurring. This medication is not recommended for children, and elderly patients may need dosage adjustment based on kidney function. In case of overdose, immediate medical attention is necessary, and blood dialysis may be helpful. This medication should be kept out of reach of children and stored in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The recommended storage temperature is between 1 and 30 degrees Celsius to maintain the medication's effectiveness.
Biconvex oval film-coated tablet with a pinkish white color
60 tablets/bottle, 60 tablets/box [10 tablets/PTP x 6]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.